US Supreme Court refuses to hear Tamiflu ‘double patenting’ case

10-03-2015

US Supreme Court refuses to hear Tamiflu ‘double patenting’ case

Crystal Eye Studio / Shutterstock.com

The US Supreme Court yesterday (March 9) refused to hear a case between Californian pharmaceutical company Gilead and India-based Natco that concerns ‘double patenting’.


US Supreme Court, Gilead, Natco, obviousness-type double patenting, Tamiflu

LSIPR